This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Ryokichi Koyama: Innovator in Heterocyclic Compounds
Introduction
Ryokichi Koyama is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of heterocyclic compounds. His work has implications in various applications, including pharmaceuticals.
Latest Patents
Koyama holds a patent for a heterocyclic compound that exhibits RORγt inhibitory activity. This compound is characterized by a specific formula that includes a pyrazole ring and various substituents. The patent highlights the compound's potential in therapeutic applications, showcasing Koyama's innovative approach to chemical design.
Career Highlights
Koyama is associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research in medicinal chemistry. His work at Takeda has allowed him to explore new avenues in drug development, contributing to the company's mission of improving patient health.
Collaborations
Koyama has collaborated with esteemed colleagues such as Satoshi Yamamoto and Junya Shirai. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.
Conclusion
Ryokichi Koyama's contributions to the field of heterocyclic compounds exemplify his innovative spirit and dedication to advancing pharmaceutical science. His work continues to inspire future research and development in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile